Reuters: Exclusive — Transatlantic divide: how U.S. pays three times more for drugs
“U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters. The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton…” (Hirschler, 10/12).